Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

✍ Scribed by Friedberg, J. W.; Mahadevan, D.; Cebula, E.; Persky, D.; Lossos, I.; Agarwal, A. B.; Jung, J.; Burack, R.; Zhou, X.; Leonard, E. J.; Fingert, H.; Danaee, H.; Bernstein, S. H.

• Book ID: 121870799
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 234 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2012.46.8793